Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
ROCKET PHARMACEUTICALS, INC. has filed 938 SEC EDGAR filings since 25 Feb 2004

SEC filing history

Showing 876-900 of 935 matching filings.

Per page
25
Current page
36
4

FORM 4 SUBMISSION

Filing date
25 Feb 2015
Reporting date
23 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Feb 2015
Reporting date
23 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Feb 2015
Reporting date
23 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Feb 2015
Reporting date
23 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Feb 2015
Reporting date
23 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Feb 2015
Reporting date
23 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-199859

424B4

Filing date
19 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-199859

424B4

Filing date
19 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

FORM 3/A SUBMISSION

Filing date
19 Feb 2015
Reporting date
17 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
19 Feb 2015
Reporting date
17 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

FORM 3/A SUBMISSION

Filing date
18 Feb 2015
Reporting date
17 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

FORM 3/A SUBMISSION

Filing date
18 Feb 2015
Reporting date
17 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

FORM 3/A SUBMISSION

Filing date
18 Feb 2015
Reporting date
17 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

FORM 3/A SUBMISSION

Filing date
18 Feb 2015
Reporting date
17 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

FORM 3/A SUBMISSION

Filing date
18 Feb 2015
Reporting date
17 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

FORM 3/A SUBMISSION

Filing date
18 Feb 2015
Reporting date
17 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
18 Feb 2015
Reporting date
17 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-199859

FWP

Filing date
18 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-199859

EFFECT filing

Filing date
17 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
17 Feb 2015
Reporting date
17 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
17 Feb 2015
Reporting date
17 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
17 Feb 2015
Reporting date
17 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
17 Feb 2015
Reporting date
17 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
17 Feb 2015
Reporting date
17 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
17 Feb 2015
Reporting date
17 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .